New research from a University of Cincinnati Cancer Center study found external beam radiation therapy is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe



